Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
HKD 1.39
(-0.71%)
HKD 1.39
(-0.71%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 80.4 Million CNY | 20000.0% |
| 2022 | 400 Thousand CNY | 0.0% |
| 2021 | 400 Thousand CNY | 0.0% |
| 2020 | 400 Thousand CNY | -82.98% |
| 2019 | 2.35 Million CNY | 0.0% |
| 2018 | 2.35 Million CNY | -20.88% |
| 2017 | 2.97 Million CNY | 0.0% |
| 2016 | 2.97 Million CNY | -60.87% |
| 2015 | 7.59 Million CNY | -14.04% |
| 2014 | 8.83 Million CNY | 0.0% |
| 2013 | 8.83 Million CNY | -22.88% |
| 2012 | 11.45 Million CNY | 61.95% |
| 2011 | 7.07 Million CNY | 5.68% |
| 2010 | 6.69 Million CNY | -4.29% |
| 2009 | 6.99 Million CNY | 0.0% |
| 2008 | 6.99 Million CNY | 0.0% |
| 2007 | 6.99 Million CNY | 0.0% |
| 2006 | - CNY | -100.0% |
| 2005 | 8.9 Million CNY | -11.0% |
| 2004 | 10 Million CNY | 0.0% |
| 2003 | 10 Million CNY | 0.0% |
| 2002 | - CNY | -100.0% |
| 2001 | 8.3 Million CNY | -42.16% |
| 2000 | 14.35 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 83.75 Million CNY | 4.17% |
| 2024 Q2 | 83.75 Million CNY | 0.0% |
| 2023 Q2 | 2.77 Million CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 Q1 | - CNY | -100.0% |
| 2023 FY | 80.4 Million CNY | 20000.0% |
| 2023 Q4 | 80.4 Million CNY | 0.0% |
| 2022 FY | 400 Thousand CNY | 0.0% |
| 2022 Q4 | 400 Thousand CNY | 0.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2022 Q1 | - CNY | -100.0% |
| 2022 Q2 | 1.81 Million CNY | 0.0% |
| 2021 FY | 400 Thousand CNY | 0.0% |
| 2021 Q2 | 400 Thousand CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q4 | 400 Thousand CNY | 0.0% |
| 2020 FY | 400 Thousand CNY | -82.98% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | 1.86 Million CNY | 0.0% |
| 2020 Q4 | 400 Thousand CNY | 0.0% |
| 2019 Q4 | 2.35 Million CNY | 0.0% |
| 2019 Q2 | 2.35 Million CNY | 0.0% |
| 2019 FY | 2.35 Million CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q4 | 2.35 Million CNY | 0.0% |
| 2018 Q2 | 2.42 Million CNY | 0.0% |
| 2018 FY | 2.35 Million CNY | -20.88% |
| 2017 Q2 | 2.97 Million CNY | 0.0% |
| 2017 Q4 | 2.97 Million CNY | 0.0% |
| 2017 FY | 2.97 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 2.97 Million CNY | -60.87% |
| 2016 Q4 | 2.97 Million CNY | 0.0% |
| 2016 Q2 | 7.59 Million CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 Q2 | 8.83 Million CNY | 0.0% |
| 2015 Q4 | 7.59 Million CNY | 0.0% |
| 2015 FY | 7.59 Million CNY | -14.04% |
| 2014 Q4 | 8.83 Million CNY | 0.0% |
| 2014 FY | 8.83 Million CNY | 0.0% |
| 2014 Q2 | 8.83 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2013 Q4 | 8.83 Million CNY | 0.0% |
| 2013 Q2 | 15.45 Million CNY | 0.0% |
| 2013 FY | 8.83 Million CNY | -22.88% |
| 2012 Q4 | 11.45 Million CNY | 0.0% |
| 2012 Q2 | 7.07 Million CNY | 0.0% |
| 2012 FY | 11.45 Million CNY | 61.95% |
| 2011 Q4 | 7.07 Million CNY | 0.0% |
| 2011 FY | 7.07 Million CNY | 5.68% |
| 2011 Q2 | 7.32 Million CNY | 0.0% |
| 2010 Q4 | 6.69 Million CNY | 0.0% |
| 2010 Q2 | 6.99 Million CNY | 0.0% |
| 2010 FY | 6.69 Million CNY | -4.29% |
| 2009 FY | 6.99 Million CNY | 0.0% |
| 2008 FY | 6.99 Million CNY | 0.0% |
| 2007 FY | 6.99 Million CNY | 0.0% |
| 2006 FY | - CNY | -100.0% |
| 2005 FY | 8.9 Million CNY | -11.0% |
| 2004 FY | 10 Million CNY | 0.0% |
| 2003 FY | 10 Million CNY | 0.0% |
| 2002 FY | - CNY | -100.0% |
| 2001 FY | 8.3 Million CNY | -42.16% |
| 2000 FY | 14.35 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -1080.617% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | 97.638% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | 33.228% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | 82.558% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -16409.24% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | 60.615% |
| Essex Bio-Technology Limited | 294.02 Million HKD | 72.655% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | 75.915% |
| PuraPharm Corporation Limited | 424.77 Million HKD | 81.072% |
| SSY Group Limited | 3.37 Billion HKD | 97.617% |
| JBM (Healthcare) Limited | 133.4 Million HKD | 39.733% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | 89.271% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 99.906% |